Techniplas Ltd’s Post

Elucid has received FDA clearance for its PlaqueIQ image analysis software. 🙌 This image analysis software will assist physicians in diagnosing cardiovascular disease non-invasively by quantifying and classifying plaque morphology using histology. It provides clinically validated information, enabling tailored treatment plans for each patient. The developments in technology in the medical industry are encouraging, as it enhances patient outcomes and promotes healthier lifestyles. As key suppliers of plastic mouldings to this sector, we are keen to see the benefits these advancements will bring. Read the full article here - https://bit.ly/4gNlWdj #MedicalIndustry #UKmfg #PlasticMoulding #Manufacturing #Plastic #Moulding #Engineering #InjectionMoulding

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics